SEARCH

SEARCH BY CITATION

References

  • 1
    Azoulay D, Samuel D, Castaing D et al. Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy. J Am Coll Surg 1999; 189: 584593.
  • 2
    Bittencourt PL, Couto CA, Leitao RM et al. No evidence of de novo amyloidosis in recipients of domino liver transplantation: 12 to 40 (mean 24) month follow-up. Amyloid 2002; 9: 194196.
  • 3
    Casas-Melley AT, Thomas PG, Krueger LJ et al. Domino as a bridge to definitive liver transplantation in a neonate. Pediatr Transplant 2002; 6: 249254.
  • 4
    Donckier V, El Nakadi I, Closset J et al. Domino hepatic transplantation using the liver from a patient with primary hyperoxaluria. Transplantation 2001; 71: 13461348.
  • 5
    Danpure C. Primary hyperoxaluria. In: ScriverCR, BeaudetAL, SlyWS, ValleD, ChildsB, KinzlerKW, VogelsteinB, eds. The molecular basis of inherited disease. New York : McGraw-Hill, 2001: 33233367.
  • 6
    Amoroso A, Pirulli D, Florian F et al. AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. J Am Soc Nephrol 2001; 12: 20722079.
  • 7
    Pirulli D, Marangella M, Amoroso A. Primary hyperoxaluria: genotype-phenotype correlation. J Nephrol 2003; 16: 297309.
  • 8
    Marangella M, Petrarulo M, Vitale C, Cosseddu D, Linari F. Plasma and urine glycolate assays for differentiating the hyperoxaluria syndromes. J Urol 1992; 148 (3 Pt 2): 986989.
  • 9
    Petrarulo M, Cerelli E, Marangella M, Cosseddu D, Vitale C, Linari F. Assay of plasma oxalate with soluble oxalate oxidase. Clin Chem 1994; 40: 20302034.
  • 10
    Petrarulo M, Pellegrino S, Marangella M, Cosseddu D, Linari F. High-performance liquid chromatographic microassay for L-glutamate:glyoxylate aminotransferase activity in human liver. Application in primary hyperoxaluria type 1. Clin Chim Acta 1993: 218: 193200.
  • 11
    Marangella M, Vitale C, Petrarulo M et al. Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure. Kidney Int 1995; 48: 182187.
  • 12
    Marangella M, Petrarulo M, Vitale C et al. Serum calcium oxalate saturation in patients on maintenance haemodialysis for primary hyperoxaluria or oxalosis-unrelated renal diseases. Clin Sci 1991; 81: 483490.
  • 13
    Watts RW, Morgan SH, Danpure CJ et al. Combined hepatic and renal transplantation in primary hyperoxaluria type I: clinical report of nine cases. Am J Med 1991; 90: 179188.
  • 14
    Marangella M. Transplantation strategies in type 1 primary hyperoxaluria: the issue of pyridoxine responsiveness. Nephrol Dial Transplant 1999; 14: 301303.
  • 15
    Watts RW. The clinical spectrum of the primary hyperoxalurias and their treatment. J Nephrol 1998; 11 (Suppl 1): 47.
  • 16
    Jamieson NV. The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984–1997. The European PH1 transplant registry report. European PH1 Transplantation Study Group. J Nephrol 1998; 11 (Suppl 1): 3641.
  • 17
    Allen AR, Thompson EM, Williams G, Watts RW, Pusey CD. Selective renal transplantation in primary hyperoxaluria type 1. Am J Kidney Dis 1996; 27: 891895.
  • 18
    Hoppe B, Langmann CB. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 2003; 18: 986991.
  • 19
    Pulvirenti A, Romito R, Sarli D, Montagnino G, Regalia E, Mazzaferro V. Donor liver transplantation from a donor with primary hyperoxaluria type I. A case report. [Abstract]. Proceedings of the 6th European Workshop on Hyperoxaluria, Hannover 2002, p. 21.
  • 20
    Monico CG, Persson M, Ford GC, Rumsby G, Milliner DS. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int 2002; 62: 392400.